{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:56:56Z","timestamp":1785455816903,"version":"3.56.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Wuhan health and Family Planning Commission research projects","award":["WG15A02 and WX18 Q31"],"award-info":[{"award-number":["WG15A02 and WX18 Q31"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10067-020-05320-z","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T19:02:41Z","timestamp":1597345361000},"page":"1211-1220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Rheumatoid arthritis\u2013associated interstitial lung disease: an overview of epidemiology, pathogenesis and management"],"prefix":"10.1007","volume":"40","author":[{"given":"Yujie","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-7701","authenticated-orcid":false,"given":"Shaoxian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"5320_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/BOR.0b013e32835f693f","volume":"25","author":"C Turesson","year":"2013","unstructured":"Turesson C (2013) Extra-articular rheumatoid arthritis. Curr Opin Rheumatol 25:360\u2013366","journal-title":"Curr Opin Rheumatol"},{"key":"5320_CR2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","volume":"127","author":"HK Lee","year":"2005","unstructured":"Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M (2005) Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127:2019\u20132027","journal-title":"Chest"},{"key":"5320_CR3","first-page":"155","volume":"9","author":"T Suda","year":"2016","unstructured":"Suda T (2016) Up-to-date information on rheumatoid arthritis-associated interstitial lung disease. Clin Med Insights Circ Respir Pulm Med 9:155\u2013162","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"5320_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62:1583\u20131591","journal-title":"Arthritis Rheum"},{"key":"5320_CR5","first-page":"62","volume":"29","author":"C Turesson","year":"2002","unstructured":"Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62\u201367","journal-title":"J Rheumatol"},{"key":"5320_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","volume":"25","author":"A Bilgici","year":"2005","unstructured":"Bilgici A, Ulusoy H, Kuru O, \u00c7elenk \u00c7, \u00dcnsal M, Danac\u0131 M (2005) Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 25:429\u2013435","journal-title":"Rheumatol Int"},{"key":"5320_CR7","first-page":"1513","volume":"35","author":"S Mori","year":"2008","unstructured":"Mori S, Cho I, Koga Y, Sugimoto M (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513\u20131521","journal-title":"J Rheumatol"},{"key":"5320_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/thx.56.8.622","volume":"56","author":"JK Dawson","year":"2001","unstructured":"Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR (2001) Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 56:622\u2013627","journal-title":"Thorax"},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","volume":"30","author":"HM Habib","year":"2011","unstructured":"Habib HM, Eisa AA, Arafat WR, Marie MA (2011) Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 30:217\u2013221","journal-title":"Clin Rheumatol"},{"key":"5320_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay E, Tarala R, Will R et al (1997) Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156:528\u2013535","journal-title":"Am J Respir Crit Care Med"},{"key":"5320_CR11","doi-asserted-by":"crossref","unstructured":"Roos Ljungberg K, Joshua V, Skogh T et al. (2019) Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis. Rheumatology (Oxford)","DOI":"10.1093\/rheumatology\/kez377"},{"key":"5320_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1479972315620746","volume":"13","author":"A Robles-Perez","year":"2016","unstructured":"Robles-Perez A, Luburich P, Rodriguez-Sanchon B, Dorca J, Nolla JM, Molina-Molina M, Narvaez-Garcia J (2016) Preclinical lung disease in early rheumatoid arthritis. Chron Respir Dis 13:75\u201381","journal-title":"Chron Respir Dis"},{"key":"5320_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E, Ellingsen T (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76:1700\u20131706","journal-title":"Ann Rheum Dis"},{"key":"5320_CR14","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of Rheumatois arthritis. NEJM 365:2205\u20132219","journal-title":"NEJM"},{"key":"5320_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","volume":"46","author":"T Bongartz","year":"2007","unstructured":"Bongartz T, Cantaert T, Atkins SR, Harle P, Myers JL, Turesson C, Ryu JH, Baeten D, Matteson EL (2007) Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology 46:70\u201375","journal-title":"Rheumatology"},{"key":"5320_CR16","first-page":"280","volume":"67","author":"F Paulin","year":"2015","unstructured":"Paulin F, Doyle TJ, Fletcher EA, Ascherman DP, Rosas IO (2015) Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis:shared mechanistic and phenotypic traits suggest overlapping disease mechanisms. Rev Investig Clin 67:280\u2013286","journal-title":"Rev Investig Clin"},{"key":"5320_CR17","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1136\/annrheumdis-2013-204912","volume":"74","author":"AJ Ytterberg","year":"2014","unstructured":"Ytterberg AJ, Joshua V, Reynisdottir G et al (2014) Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis 74:1772\u20131777","journal-title":"Ann Rheum Dis"},{"key":"5320_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10067-018-04421-0","volume":"38","author":"CS Correia","year":"2019","unstructured":"Correia CS, Briones MR, Guo R, Ostrowski RA (2019) Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease. Clin Rheumatol 38:1201\u20131206","journal-title":"Clin Rheumatol"},{"key":"5320_CR19","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3899\/jrheum.111478","volume":"39","author":"LH Jearn","year":"2012","unstructured":"Jearn LH, Kim TY (2012) Level of anticitrullinated peptide\/protein antibody is not associated with lung diseases in rheumatoid arthritis. J Rheumatol 39:1493\u20131494","journal-title":"J Rheumatol"},{"key":"5320_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.clinbiochem.2006.06.004","volume":"39","author":"C Korkmaz","year":"2006","unstructured":"Korkmaz C, Us T, Kasifoglu T et al (2006) Anti-cyclic citrullinated peptide [CCP] antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem 39:961\u2013965","journal-title":"Clin Biochem"},{"key":"5320_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.clinbiochem.2008.06.014","volume":"41","author":"N Inui","year":"2008","unstructured":"Inui N, Enomoto N, Suda T, Kageyama Y, Watanabe H, Chida K (2008) Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 41:1074\u20131077","journal-title":"Clin Biochem"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3899\/jrheum.131341","volume":"41","author":"J Zhu","year":"2014","unstructured":"Zhu J, Zhou Y, Chen X, Li J (2014) A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol 41:1282\u20131289","journal-title":"J Rheumatol"},{"key":"5320_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1165\/rcmb.2005-0460OC","volume":"37","author":"HW Young","year":"2007","unstructured":"Young HW, Williams OW, Chandra D et al (2007) Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5\u2032 elements. Am J Respir Cell Mol Biol 37:273\u2013290","journal-title":"Am J Respir Cell Mol Biol"},{"key":"5320_CR24","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, Gonz\u00e1lez-P\u00e9rez MI, Mej\u00eda M, Buend\u00eda-Rold\u00e1n I, Falf\u00e1n-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac\u2019h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Liot\u00e9 H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Cl\u00e9ment A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieud\u00e9 P (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med 379:2209\u20132219","journal-title":"N Engl J Med"},{"key":"5320_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1165\/rcmb.2017-0046OC","volume":"57","author":"BA Helling","year":"2017","unstructured":"Helling BA, Gerber AN, Kadiyala V, Sasse SK, Pedersen BS, Sparks L, Nakano Y, Okamoto T, Evans CM, Yang IV, Schwartz DA (2017) Regulation of MUC5B expression in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 57:91\u201399","journal-title":"Am J Respir Cell Mol Biol"},{"key":"5320_CR26","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA (2011) A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364:1503\u20131512","journal-title":"N Engl J Med"},{"key":"5320_CR27","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMc1013504","volume":"364","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Noth I, Garcia JG et al (2011) A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 364:1576\u20131577","journal-title":"N Engl J Med"},{"key":"5320_CR28","doi-asserted-by":"publisher","first-page":"1602314","DOI":"10.1183\/13993003.02314-2016","volume":"49","author":"PA Juge","year":"2017","unstructured":"Juge PA, Borie R, Kannengiesser C et al (2017) Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J 49:1602314","journal-title":"Eur Respir J"},{"key":"5320_CR29","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/jama.2013.5827","volume":"309","author":"AL Peljto","year":"2013","unstructured":"Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JGN, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, Gibson KF, Seibold MA, Brown KK, Talbert JL, Markin C, Kossen K, Seiwert SD, Murphy E, Noth I, Schwarz MI, Kaminski N, Schwartz DA (2013) Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309:2232\u20132239","journal-title":"JAMA"},{"key":"5320_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/thoraxjnl-2019-214061","volume":"74","author":"A Adegunsoye","year":"2019","unstructured":"Adegunsoye A (2019) MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis. Thorax 74:1111\u20131112","journal-title":"Thorax"},{"key":"5320_CR31","first-page":"97","volume":"9","author":"PJ Charles","year":"1991","unstructured":"Charles PJ, Sweatman MC, Markwick JR, Maini RN (1991) HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis. Dis Markers 9:97\u2013101","journal-title":"Dis Markers"},{"key":"5320_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0002-9343(87)90013-1","volume":"82","author":"TE Scott","year":"1987","unstructured":"Scott TE, Wise RA, Hochberg MC, Wigley FM (1987) HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. Am J Med 82:765\u2013771","journal-title":"Am J Med"},{"key":"5320_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/rheumatology\/32.9.794","volume":"32","author":"MC Hillarby","year":"1993","unstructured":"Hillarby MC, McMahon MJ, Grennan DM et al (1993) HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol 32:794\u2013797","journal-title":"Br J Rheumatol"},{"key":"5320_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2169\/internalmedicine.33.612","volume":"33","author":"Y Sugiyama","year":"1994","unstructured":"Sugiyama Y, Ohno S, Kano S et al (1994) Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54. Intern Med 33:612\u2013614","journal-title":"Intern Med"},{"key":"5320_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico BR, Avila NA, Chow CK, Novero LJ, Wu HP, Ren P, MacDonald S, Travis WD, Stylianou MP, Rosas IO (2008) Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 168:159\u2013166","journal-title":"Arch Intern Med"},{"key":"5320_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1053\/sarh.2001.27719","volume":"31","author":"SA Albano","year":"2001","unstructured":"Albano SA, Santana-Sahagun E, Weisman MH (2001) Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 31:146\u2013159","journal-title":"Semin Arthritis Rheum"},{"key":"5320_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/03009742.2018.1477989","volume":"48","author":"T Matsuo","year":"2019","unstructured":"Matsuo T, Hashimoto M, Ito I, Kubo T, Uozumi R, Furu M, Ito H, Fujii T, Tanaka M, Terao C, Kono H, Mori M, Hamaguchi M, Yamamoto W, Ohmura K, Morita S, Mimori T (2019) Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study. Scand J Rheumatol 48:87\u201394","journal-title":"Scand J Rheumatol"},{"key":"5320_CR38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","volume":"191","author":"TJ Doyle","year":"2015","unstructured":"Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, el-Chemaly SY, Washko GR, Hunninghake GM, Choi AMK, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO (2015) Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med 191:1403\u20131412","journal-title":"Am J Respir Crit Care Med"},{"key":"5320_CR39","doi-asserted-by":"publisher","first-page":"14897","DOI":"10.1038\/srep14897","volume":"5","author":"T Wang","year":"2015","unstructured":"Wang T, Zheng XJ, Liang BM, Liang ZA (2015) Clinical features of rheumatoid arthritis-associated interstitial lung disease. Sci Rep 5:14897","journal-title":"Sci Rep"},{"key":"5320_CR40","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","volume":"36","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li H, Wu N, Dong X, Zheng Y (2017) Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol 36:817\u2013823","journal-title":"Clin Rheumatol"},{"key":"5320_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/radiol.13130187","volume":"270","author":"D Assayag","year":"2014","unstructured":"Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, King TE, Collard HR, Kim DS, Lee JS (2014) Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 270:583\u2013588","journal-title":"Radiology"},{"key":"5320_CR42","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","volume":"107","author":"JJ Solomon","year":"2013","unstructured":"Solomon JJ, Ryu JH, Tazelaar HD, Myers JL, Tuder R, Cool CD, Curran-Everett D, Fischer A, Swigris JJ, Brown KK (2013) Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease [RA-ILD]. Respir Med 107:1247\u20131252","journal-title":"Respir Med"},{"key":"5320_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11926-010-0116-z","volume":"12","author":"DP Ascherman","year":"2010","unstructured":"Ascherman DP (2010) Interstitial lung disease in rheumatoid arthritis. Curr Rheumatol Rep 12:363\u2013369","journal-title":"Curr Rheumatol Rep"},{"key":"5320_CR44","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, van Uden JH, Lee JS, King TE, Collard HR (2010) Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35:1322\u20131132","journal-title":"Eur Respir J"},{"key":"5320_CR45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/rheumatology\/40.9.1022","volume":"40","author":"BA Rajasekaran","year":"2001","unstructured":"Rajasekaran BA, Shovlin D, Lord P, Kelly CA (2001) Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 40:1022\u20131025","journal-title":"Rheumatology (Oxford)"},{"key":"5320_CR46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King te Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS\/ERS Committee on Idiopathic Interstitial Pneumonias (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"5320_CR47","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.humpath.2008.09.001","volume":"39","author":"AL Katzenstein","year":"2008","unstructured":"Katzenstein AL, Mukhopadhyay S, Myers JL (2008) Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 39:1562\u20131581","journal-title":"Hum Pathol"},{"key":"5320_CR48","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chest.2017.05.015","volume":"152","author":"TJ Doyle","year":"2017","unstructured":"Doyle TJ, Dellaripa PF (2017) Lung manifestations in the rheumatic diseases. Chest 152:1283\u20131295","journal-title":"Chest"},{"key":"5320_CR49","doi-asserted-by":"crossref","unstructured":"Jacob J, Hirani N, van Moorsel CHM et al. (2019) Predicting outcomes in rheumatoid arthritis related interstitial lung disease. Eur Respir J 53(1)","DOI":"10.1183\/13993003.00869-2018"},{"key":"5320_CR50","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00431-011-1461-2","volume":"170","author":"VA Caiulo","year":"2011","unstructured":"Caiulo VA, Gargani L, Caiulo S, Fisicaro A, Moramarco F, Latini G, Picano E (2011) Lung ultrasound in bronchiolitis: comparison with chest X-ray. Eur J Pediatr 170:1427\u20131433","journal-title":"Eur J Pediatr"},{"key":"5320_CR51","first-page":"180","volume":"60","author":"M Doveri","year":"2008","unstructured":"Doveri M, Frassi F, Consensi A, Vesprini E, Gargani L, Tafuri M, Picano E, Della Rossa A, Delle Sedie A, d'Ascanio A, Giacomelli C, Bazzichi L, Bombardieri S (2008) Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis. Reumatismo 60:180\u2013184","journal-title":"Reumatismo"},{"key":"5320_CR52","first-page":"681","volume":"90","author":"G Mathis","year":"2001","unstructured":"Mathis G, Gehmacher O (2001) Lung and pleural ultrasound. Praxis (Bern 1994) 90:681\u2013686","journal-title":"Praxis (Bern 1994)"},{"key":"5320_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00134-012-2513-4","volume":"38","author":"G Volpicelli","year":"2012","unstructured":"Volpicelli G, Elbarbary M, Blaivas M et al (2012) International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 38:577\u2013591","journal-title":"Intensive Care Med"},{"key":"5320_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2001-11252","volume":"22","author":"S Wohlgenannt","year":"2001","unstructured":"Wohlgenannt S, Gehmacher O, Gehmacher U, Kopf A, Mathis G (2001) Sonographic findings in interstitial lung diseases. Ultraschall Med 22:27\u201331","journal-title":"Ultraschall Med"},{"key":"5320_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ultrasmedbio.2008.10.009","volume":"35","author":"M Sperandeo","year":"2009","unstructured":"Sperandeo M, Varriale A, Sperandeo G, Filabozzi P, Piattelli ML, Carnevale V, Decuzzi M, Vendemiale G (2009) Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med Biol 35:723\u2013729","journal-title":"Ultrasound Med Biol"},{"key":"5320_CR56","first-page":"199","volume":"32","author":"FC Moazedi-Fuerst","year":"2014","unstructured":"Moazedi-Fuerst FC, Kielhauser SM, Scheidl S et al (2014) Ultrasound screening for interstitial lung disease in rheumatoid arthritis. Clin Exp Rheumatol 32:199\u2013203","journal-title":"Clin Exp Rheumatol"},{"key":"5320_CR57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, Mannina A, Olson AL, Russell G, Tsuchiya Y, Yunt ZX, Zelarney PT, Brown KK, Swigris JJ (2016) Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 47:588\u2013596","journal-title":"Eur Respir J"},{"key":"5320_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE et al (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183:431\u2013440","journal-title":"Am J Respir Crit Care Med"},{"key":"5320_CR59","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.39971","volume":"69","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL (2017) Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol 69:542\u2013549","journal-title":"Arthritis Rheumatol"},{"key":"5320_CR60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/ard.61.6.517","volume":"61","author":"JK Dawson","year":"2002","unstructured":"Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR (2002) Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 61:517\u2013521","journal-title":"Ann Rheum Dis"},{"key":"5320_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","volume":"19","author":"A Manfredi","year":"2019","unstructured":"Manfredi A, Cassone G, Cerri S et al (2019) Diagnostic accuracy of a velcro sound detector [VECTOR] for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study [INterStitial pneumonia in rheumatoid arthritis with an electronic device]. BMC Pulm Med 19:111","journal-title":"BMC Pulm Med"},{"key":"5320_CR62","doi-asserted-by":"crossref","unstructured":"Wu EK, Ambrosini RD, Kottmann RM et al. (2019) Reinterpreting evidence of rheumatoid arthritis-associated interstitial lung disease to understand etiology. Curr Rheumatol Rev","DOI":"10.2174\/1573397115666190116102451"},{"key":"5320_CR63","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, Gill RR, Hatabu H, Nishino M, Murphy DJ, Iannaccone CK, Mahmoud TG, Frits ML, Lu B, Rosas IO, Dellaripa PF, Weinblatt ME, Karlson EW, Shadick NA, Doyle TJ (2019) Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol 71:1472\u20131482","journal-title":"Arthritis Rheumatol"},{"key":"5320_CR64","first-page":"76","volume":"70","author":"F Paulin","year":"2018","unstructured":"Paulin F, Mercado JF, Fern\u00e1ndez ME, Caro FM, Alberti ML, Fassola LA (2018) Correlation between lung and joint involvement in patients with rheumatoid arthritis and interstitial lung disease: a cross-sectional study. Rev Investig Clin 70:76\u201381","journal-title":"Rev Investig Clin"},{"key":"5320_CR65","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King te Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS\/ERS Committee on Idiopathic Interstitial Pneumonias (2013) ATS\/ERS Committee on idiopathic interstitial pneumonias. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"5320_CR66","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0034-1371542","volume":"35","author":"F Lake","year":"2014","unstructured":"Lake F, Proudman S (2014) Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med 35:222\u2013238","journal-title":"Semin Respir Crit Care Med"},{"key":"5320_CR67","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1517\/14656560802591430","volume":"9","author":"C Kelly","year":"2008","unstructured":"Kelly C, Saravanan V (2008) Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease. Expert Opin Pharmacother 9:3221\u20133230","journal-title":"Expert Opin Pharmacother"},{"key":"5320_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/1753465816668780","volume":"11","author":"A Picchianti Diamanti","year":"2017","unstructured":"Picchianti Diamanti A, Markovic M, Argento G, Giovagnoli S, Ricci A, Lagan\u00e0 B, D\u2019Amelio R (2017) Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review. Ther Adv Respir Dis 11:64\u201372","journal-title":"Ther Adv Respir Dis"},{"key":"5320_CR69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73:492\u2013509","journal-title":"Ann Rheum Dis"},{"key":"5320_CR70","doi-asserted-by":"publisher","first-page":"e003132","DOI":"10.1136\/bmjopen-2013-003132","volume":"3","author":"H Hozumi","year":"2013","unstructured":"Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Kono M, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Suda T, Chida K (2013) Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 3:e003132","journal-title":"BMJ Open"},{"key":"5320_CR71","first-page":"1850","volume":"20","author":"RJ McKendry","year":"1993","unstructured":"McKendry RJ, Dale P (1993) Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 20:1850\u20131856","journal-title":"J Rheumatol"},{"key":"5320_CR72","first-page":"1507","volume-title":"Oxford textbook of medicine","author":"DJ Hendrick","year":"2005","unstructured":"Hendrick DJ, Spickett GP (2005) Drug-induced lung disease. In: Oxford textbook of medicine, vol 2. Oxford University Press, Oxford, pp 1507\u20131512"},{"key":"5320_CR73","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","volume":"66","author":"R Conway","year":"2014","unstructured":"Conway R, Low C, Coughlan RJ, O'Donnell MJ, Carey JJ (2014) Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol 66:803\u2013812","journal-title":"Arthritis Rheumatol"},{"key":"5320_CR74","doi-asserted-by":"publisher","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","volume":"9","author":"P Kiely","year":"2019","unstructured":"Kiely P, Busby AD, Nikiphorou E et al (2019) Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open 9:e028466","journal-title":"BMJ Open"},{"key":"5320_CR75","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/rheumatology\/kep052","volume":"48","author":"T Sawada","year":"2009","unstructured":"Sawada T, Inokuma S, Sato T, Otsuka T, Saeki Y, Takeuchi T, Matsuda T, Takemura T, Sagawa A, on behalf of the Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology (2009) Leflunomide-induced interstitial lung disease:prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford) 48:1069\u20131072","journal-title":"Rheumatology (Oxford)"},{"key":"5320_CR76","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3899\/jrheum.150674","volume":"43","author":"R Conway","year":"2016","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ (2016) Leflunomide use and risk of lung disease in rheumatoid arthritis: a systematic literature review and metaanalysis of randomized controlled trials. J Rheumatol 43:855\u2013860","journal-title":"J Rheumatol"},{"key":"5320_CR77","doi-asserted-by":"publisher","first-page":"256Y26","DOI":"10.1016\/j.semarthrit.2010.11.002","volume":"41","author":"R Perez-Alvarez","year":"2011","unstructured":"Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C et al (2011) Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum 41:256Y26","journal-title":"Semin Arthritis Rheum"},{"key":"5320_CR78","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/rheumatology\/ker289","volume":"50","author":"AV Hadjinicolaou","year":"2011","unstructured":"Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Ostor AJK (2011) Non-infectious pulmonary complications of newer biological agents for rheumatic diseases\u2014a systematic literature review. Rheumatology (Oxford) 50:2297\u20132305","journal-title":"Rheumatology (Oxford)"},{"key":"5320_CR79","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/rheumatology\/ker309","volume":"51","author":"F Pearce","year":"2012","unstructured":"Pearce F, Johnson SR, Courtney P (2012) Interstitial lung disease following certolizumab pegol. Rheumatology (Oxford) 51:578\u2013580","journal-title":"Rheumatology (Oxford)"},{"key":"5320_CR80","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1136\/ard.2011.151092","volume":"70","author":"T Koike","year":"2011","unstructured":"Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Ito K, Yamanaka H (2011) Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients. Ann Rheum Dis 70:2148\u20132151","journal-title":"Ann Rheum Dis"},{"key":"5320_CR81","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2169\/internalmedicine.2226-18","volume":"58","author":"I Kurata","year":"2019","unstructured":"Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F, Ohyama A, Yagishita M, Osada A, Ebe H, Kawaguchi H, Takahashi H, Hagiwara S, Asashima H, Kondo Y, Matsumoto I, Sumida T (2019) Effect of biological disease-modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis. Intern Med 58:1703\u20131712","journal-title":"Intern Med"},{"key":"5320_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","volume":"48","author":"C Fern\u00e1ndez-D\u00edaz","year":"2018","unstructured":"Fern\u00e1ndez-D\u00edaz C, Loricera J, Casta\u00f1eda S, L\u00f3pez-Mej\u00edas R, Ojeda-Garc\u00eda C, Oliv\u00e9 A, Rodr\u00edguez-Muguruza S, Carreira PE, P\u00e9rez-Sandoval T, Retuerto M, Cervantes-P\u00e9rez EC, Flores-Robles BJ, Hern\u00e1ndez-Cruz B, Urruticoechea A, Ma\u00edz-Alonso O, Arboleya L, Bonilla G, Hern\u00e1ndez-Rodr\u00edguez \u00cd, Palma D, Delgado C, Exp\u00f3sito-Molinero R, Ruibal-Escribano A, \u00c1lvarez-Rodr\u00edguez B, Blanco-Madrigal J, Bernal JA, Vela-Casasempere P, Rodr\u00edguez-G\u00f3mez M, Fito C, Ortiz-Sanju\u00e1n F, Narv\u00e1ez J, Moreno M, L\u00f3pez-Corbeto M, Mena-V\u00e1zquez N, Aguilera-Cros C, Romero-Yuste S, Ord\u00f3\u00f1ez S, Villa-Blanco I, Gonz\u00e9lez-Vela MC, Mora-Cuesta V, Palmou-Fontana N, Hern\u00e1ndez JL, Gonz\u00e1lez-Gay MA, Blanco R (2018) Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients. Semin Arthritis Rheum 48:22\u201327","journal-title":"Semin Arthritis Rheum"},{"key":"5320_CR83","unstructured":"Fui A, Bergantini L, Selvi E et al (2019) Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis. Intern Med J 9"},{"key":"5320_CR84","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","volume":"56","author":"MY Md Yusof","year":"2017","unstructured":"Md Yusof MY, Kabia A, Darby M, Lettieri G, Beirne P, Vital EM, Dass S, Emery P (2017) Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10\u00a0years\u2019 experience at a single centre. Rheumatology (Oxford) 56:1348\u20131357","journal-title":"Rheumatology (Oxford)"},{"key":"5320_CR85","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/rheumatology\/ker290","volume":"51","author":"AV Hadjinicolaou","year":"2012","unstructured":"Hadjinicolaou AV, Nisar MK, Parfrey H, Chilvers ER, Ostor AJK (2012) Non-infectious pulmonary toxicity of rituximab: a systematic review. Rheumatology (Oxford) 51:653\u2013662","journal-title":"Rheumatology (Oxford)"},{"key":"5320_CR86","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0272-5231(05)70109-X","volume":"19","author":"LT Tanoue","year":"1998","unstructured":"Tanoue LT (1998) Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 19:667\u2013685","journal-title":"Clin Chest Med"},{"key":"5320_CR87","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3346\/jkms.2002.17.2.270","volume":"17","author":"HK Chang","year":"2002","unstructured":"Chang HK, Park W, Ryu DS (2002) Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report. J Korean Med Sci 17:270\u2013273","journal-title":"J Korean Med Sci"},{"key":"5320_CR88","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/BOR.0000000000000270","volume":"28","author":"B Wallace","year":"2016","unstructured":"Wallace B, Vummidi D, Khanna D (2016) Management of connective tissue diseases associated interstitial lung disease: a review of the published literature. Curr Opin Rheumatol 28:236\u2013245","journal-title":"Curr Opin Rheumatol"},{"key":"5320_CR89","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"DP Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM, Sclerodema Lung Study II Investigators (2016) Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease [SLS II]: a randomised controlled, double-blind, parallel group trial. Lancet Respir Med 4:708\u2013719","journal-title":"Lancet Respir Med"},{"key":"5320_CR90","doi-asserted-by":"publisher","first-page":"105700","DOI":"10.1016\/j.intimp.2019.105700","volume":"74","author":"C Wu","year":"2019","unstructured":"Wu C, Lin H, Zhang X (2019) Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 [ATF3]. Int Immunopharmacol 74:105700","journal-title":"Int Immunopharmacol"},{"key":"5320_CR91","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s12325-019-01086-2","volume":"36","author":"JJ Solomon","year":"2019","unstructured":"Solomon JJ, Danoff SK, Goldberg HJ et al (2019) Trail network. The design and rationale of the Trail1 trial: a randomized double-blind phase 2 clinical trial of Pirfenidone in rheumatoid arthritis-associated interstitial lung disease. Adv Ther 36:3279\u20133287","journal-title":"Adv Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05320-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:22:30Z","timestamp":1650536550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05320-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05320-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}